AbCellera Biologics Inc.ABCLNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank67
5Y CAGR-83.7%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-83.7%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.07% |
| Q3 2025 | -3.29% |
| Q2 2025 | 4.30% |
| Q1 2025 | -1.20% |
| Q4 2024 | -2.32% |
| Q3 2024 | -1.39% |
| Q2 2024 | -3.46% |
| Q1 2024 | -1.68% |
| Q4 2023 | -1.59% |
| Q3 2023 | -1.62% |
| Q2 2023 | 2.62% |
| Q1 2023 | -2.79% |
| Q4 2022 | -0.74% |
| Q3 2022 | -2.60% |
| Q2 2022 | 0.09% |
| Q1 2022 | 20.76% |
| Q4 2021 | 12.44% |
| Q3 2021 | 1.81% |
| Q2 2021 | 2.07% |
| Q1 2021 | 12.23% |
| Q4 2020 | 606.21% |
| Q3 2020 | -8.27% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |